Keith Gelfand

Keith Gelfand has extensive experience in accounting and finance, currently serving as the Accounting Manager for Research and Development at Corcept Therapeutics since June 2020. Prior roles include consulting as an Accounting Manager for Jazz Pharmaceuticals and as a Senior Accounting Manager for Revance Therapeutics. Keith has also held positions such as Interim CFO at Elbow Room and Global Accounting Manager at Strategic Decisions Group. Additional experience encompasses work as an Inventory Accountant at Fujitsu and various accounting roles at SamTrans, SurveyMonkey, Stella & Dot, and Plaxo. Keith Gelfand holds a Bachelor of Science in Accounting from San Jose State University and continued education at Stanford University.